Bonum Certa Men Certa

Access to Medicine is More Important Than Patents

Pills



Summary: Some of the latest news about patents that impede/deny access to crucial medication; strategic litigation from the generics sector, seeking to invalidate patents and then offer low-cost alternatives

A COUPLE of weeks ago we wrote about various patent monopolies whose value to society is questionable. At one point we highlighted news about a patent case which led to massive penalties ($70,000,000) and medicine embargoes. That was Amgen.



Last week Amgen's patent disputes were brought up again by Managing IP. To quote: (it's mostly restricted in terms of access)

The permanent injunction [i.e. embargo] granted by the District of Delaware in the dispute between Amgen and Sanofi/Regeneron over cholesterol-lowering treatment has been vacated, in a decision that also included some implications for the USPTO’s practice of granting broad antibody claims

The Federal Circuit has vacated the permanent injunction in the dispute between Amgen and Sanofi/Regeneron over cholesterol-lowering treatment.


It's hard to see how sanctions like embargoes can ever benefit society, especially when life-saving medicine is at stake. It's saddening to see almost no sites (bar IP Watch perhaps) speaking about this. What's worse, now that there's positive change, owing to the US Supreme Court, sites like this are promoting the illusion that doing the right thing on patents would cause death in "developing nations" -- the very opposite of what is true. To quote:

On May 30th, the Supreme Court ruled in Impression Products, Inc. v. Lexmark International, Inc. that all patent rights are automatically exhausted upon the sale of a product irrespective of contract stipulations and regardless of whether the sale is made domestically or internationally. While the dispute in this case involved articles of manufacture, the decision has strong implications for the biotechnology and pharmaceutical Industry, and may make it easier for drugs sold legally overseas to make their way back to the U.S. market.

[...]

Another possible effect of the Lexmark decision is a decrease in drug donations from pharmaceutical companies to developing nations...


This is nonsense. If anything, the ruling compels companies to focus less (in their business model) on patents. We used to write a great deal about the sham such "donations" tend to be; sometimes they just experiment on a population, under the guise of philanthropy or charity. Production costs are minuscule anyway and what's expensive is risk of litigation due to clinical trials gone awry. We wrote about companies such as Merck and Novartis in relation to this (mostly half a decade ago) and speaking of which, watch what Patently-O published a few days ago. It is now a platform for patent radicals from Novartis (malicious company in the patent sense) and the notorious WIPO. It's easy to see what they want and it has nothing to do with public interests.

In Japan, according to last week's IAM blog post, there's now a debate (and lawsuit) that spills over to the US. Generics versus patents again:

In order to submit Paragraph IV certifications, Sawai will reportedly conduct invalidity searches for patents which protect original drugs and that have significant patent terms remaining. By invalidating patents for original drugs, Sawai expects to increase sales of its generic drugs. From the early 2020s, Sawai plans to release one or two generic drugs each year in the United States.


This is very good. Sawai would therefore improve access to medicine at affordable prices.

Recent Techrights' Posts

SoylentNews Grows Up, Registers as a Business, Site Traffic Reportedly Grows
More people realise that social control media may in fact be a passing fad
 
Garden Season Starts Today
Outdoor time, officially...
More Information About Public Talks That Richard Stallman Gave This Week in Europe
Two talks in Switzerland
Engadget is Still a Spamfarm, It's Just an Amazon Catalogue (SPAM/SEO), a Sea of Junk Disguised as "Articles" With Few 'Fillers' (Real Articles) in Between
Engadget writes for bots now, not for humans
Richard Stallman's Talks in Switzerland This Week
We need to put an end to 'cancer culture'; it's trying to kill people and it is even swatting people
Over at Tux Machines...
GNU/Linux news for the past day
IRC Proceedings: Thursday, March 28, 2024
IRC logs for Thursday, March 28, 2024
[Meme] EPO's New Ways of Working (NWoW), a.k.a. You Don't Even Get a Desk at Work and Cannot be Near Known Colleagues
Seems more like union-busting (divide and rule)
Hiding Microsoft's Culpability in Security Breaches and Other Major Blunders (in the United Kingdom, This May Mean You Can't Get Food)
Total Cost of Ownership (TCO) is vast
Giving back to the community
Reprinted with permission from Daniel Pocock
Links 28/03/2024: Sega, Nintendo, and Bell Layoffs
Links for the day
Open letter to the ACM regarding Codes of Conduct impersonating the Code of Ethics
Reprinted with permission from Daniel Pocock
With 9 Mentions of Azure In Its Latest Blog Post, Canonical is Again Promoting Microsoft and Intel Vendor Lock-in, Surveillance, Back Doors, Considerable Power Waste, and Defects That Cannot be Fixed
Microsoft did not even have to buy Canonical (for Canonical to act like it happened)
Links 28/03/2024: GAFAM Replacing Full-Time Workers With Interns Now
Links for the day
Consent & Debian's illegitimate constitution
Reprinted with permission from Daniel Pocock
The Time Our Server Host Died in a Car Accident
If Debian has internal problems, then they need to be illuminated and then tackled, at the very least in order to ensure we do not end up with "Deadian"
China's New 'IT' Rules Are a Massive Headache for Microsoft
On the issue of China we're neutral except when it comes to human rights issues
Over at Tux Machines...
GNU/Linux news for the past day
IRC Proceedings: Wednesday, March 27, 2024
IRC logs for Wednesday, March 27, 2024
WeMakeFedora.org: harassment decision, victory for volunteers and Fedora Foundations
Reprinted with permission from Daniel Pocock
Links 27/03/2024: Terrorism Grows in Africa, Unemployment in Finland Rose Sharply in a Year, Chinese Aggression Escalates
Links for the day
Links 27/03/2024: Ericsson and Tencent Layoffs
Links for the day
Amid Online Reports of XBox Sales Collapsing, Mass Layoffs in More Teams, and Windows Making Things Worse (Admission of Losses, Rumours About XBox Canceled as a Hardware Unit)...
Windows has loads of issues, also as a gaming platform
Links 27/03/2024: BBC Resorts to CG Cruft, Akamai Blocking Blunders in Piracy Shield
Links for the day
Android Approaches 90% of the Operating Systems Market in Chad (Windows Down From 99.5% 15 Years Ago to Just 2.5% Right Now)
Windows is down to about 2% on the Web-connected client side as measured by statCounter
Sainsbury's: Let Them Eat Yoghurts (and Microsoft Downtimes When They Need Proper Food)
a social control media 'scandal' this week
IRC Proceedings: Tuesday, March 26, 2024
IRC logs for Tuesday, March 26, 2024
Over at Tux Machines...
GNU/Linux news for the past day
Windows/Client at Microsoft Falling Sharply (Well Over 10% Decline Every Quarter), So For His Next Trick the Ponzi in Chief Merges Units, Spices Everything Up With "AI"
Hiding the steep decline of Windows/Client at Microsoft?
Free technology in housing and construction
Reprinted with permission from Daniel Pocock
We Need Open Standards With Free Software Implementations, Not "Interoperability" Alone
Sadly we're confronting misguided managers and a bunch of clowns trying to herd us all - sometimes without consent - into "clown computing"
Microsoft's Collapse in the Web Server Space Continued This Month
Microsoft is the "2%", just like Windows in some countries